These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25912755)

  • 1. Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.
    Montironi R; Santoni M; Goteri G; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
    Hum Pathol; 2015 Jul; 46(7):1040-4. PubMed ID: 25912755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.
    Paner GP; Cox RM; Richards K; Akki A; Gokden N; Lopez-Beltran A; Krausz T; McKenney JK; Steinberg GD
    Am J Surg Pathol; 2014 Sep; 38(9):1251-9. PubMed ID: 25133708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudocarcinomatous hyperplasia of the urinary bladder.
    Wu A
    Arch Pathol Lab Med; 2014 Oct; 138(10):1268-71. PubMed ID: 25268187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.
    Li C; Xue H; Lei Y; Zhu J; Yang B; Gai X
    Pathol Res Pract; 2014 Dec; 210(12):799-803. PubMed ID: 25445116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.
    Amin MB; McKenney JK; Paner GP; Hansel DE; Grignon DJ; Montironi R; Lin O; Jorda M; Jenkins LC; Soloway M; Epstein JI; Reuter VE;
    Eur Urol; 2013 Jan; 63(1):16-35. PubMed ID: 23083804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
    Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of GATA3 immunostaining in tumor diagnosis: a review.
    Ordóñez NG
    Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic pitfalls of rare urinary bladder tumors: differential diagnosis of lymphoma-like carcinoma of the bladder--a clinicopathologic study and literature review.
    Wronski S; Marszalek A
    J Clin Oncol; 2011 Mar; 29(8):e196-9. PubMed ID: 21189383
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmacytoid urothelial carcinoma of the bladder.
    Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
    Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant lymphoma case with urinary cytology mimicking that of urothelial carcinoma.
    Takahashi H; Shimazaki H; Oda T; Endo H; Sekitsuka H; Maekawa K; Katsurada Y; Sato K; Ito K; Nakanishi K; Tamai S
    Cytopathology; 2013 Dec; 24(6):412-4. PubMed ID: 23078009
    [No Abstract]   [Full Text] [Related]  

  • 18. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
    Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
    Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
    Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
    Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nest-like features in bladder, simulating the nested variant of urothelial carcinoma.
    Patriarca C; Colecchia M; Lopez-Beltran A; Sirugo G; Di Pasquale M; Bollito E
    Int J Surg Pathol; 2011 Feb; 19(1):11-9. PubMed ID: 20034978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.